Literature DB >> 23223733

[Assessment of tuberculosis treatment accessibility for patients co-infected or not with the human immunodeficiency virus].

Ana Maria da Silveira Rodrigues1, Lúcia Marina Scatena, Silvia Helena Figueiredo Vendramini, Silvia Rita Marin da Silva Canini, Tereza Cristina Scatena Villa, Elucir Gir.   

Abstract

This study aimed to evaluate accessibility to treatment for people with TB co-infected or not with HIV. This cross-sectional study addressed issues regarding accessibility to treatment in a city in the interior of São Paulo state, Brazil. The instrument Primary Care Assessment Tool was utilized with 95 people. To evaluate access to treatment, Student's t test was used. The mean scores of variables were analyzed separately and compared between two groups (people with TB co-infected with HIV and people with TB not co-infected with HIV ). Mean scores showed that HIV co-infected people presented greater difficulties in gaining access than those not co-infected. Professionals visited co-infected people more often when compared to those not co-infected; the co-infected people almost never accessed treatment for their disease in the Health Unit nearest their home. There is, therefore, the need for greater integration and communication between the programs for treatment of Tuberculosis and STD/AIDS.

Entities:  

Mesh:

Year:  2012        PMID: 23223733     DOI: 10.1590/s0080-62342012000500018

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  2 in total

1.  Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil.

Authors:  R Cunha; M Maruza; U R Montarroyos; I Coimbra; D de B Miranda-Filho; M de F Albuquerque; H R Lacerda; Raa Ximenes
Journal:  BMC Infect Dis       Date:  2017-02-10       Impact factor: 3.090

2.  Access to medicines by patients of the primary health care in the Brazilian Unified Health System.

Authors:  Juliana Álvares; Augusto Afonso Guerra; Vânia Eloisa de Araújo; Alessandra Maciel Almeida; Carolina Zampirolli Dias; Bruna de Oliveira Ascef; Ediná Alves Costa; Ione Aquemi Guibu; Orlando Mario Soeiro; Silvana Nair Leite; Margô Gomes de Oliveira Karnikowski; Karen Sarmento Costa; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.